Rachel Haurwitz
President and Chief Executive Officer at Caribou Biosciences
Meet Rachel Haurwitz
Haurwitz co-founded Caribou Biosciences in 2011 with Nobel Prize winner Jennifer Doudna and other CRISPR scientists. Caribou is a clinical-stage company developing an internal pipeline of off-the-shelf genome-edited CAR-T and CAR-NK cell therapies for oncology. In 2014, she was named by Forbes Magazine to the “30 Under 30” list in Science and Healthcare, and in 2016, Fortune Magazine added her to the “40 Under 40” list of the most influential young people in business. In 2018, the Association for Women in Science recognized Haurwitz with the annual Next Generation Award. She also serves on the board of directors of the Biotechnology Organization (BIO).